Ondansetron ODT 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FA0RE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,905
Award facts
- Contract value 100% obligated
- $10,904.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $10,904.64 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Ondansetron ODT 4 mg tablets in a 30-count package, with completion targeted for December 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a critical position in the federal medical procurement supply chain, particularly for military and veteran healthcare systems. The company has demonstrated extensive capability in fulfilling federal procurement requirements across multiple therapeutic domains, including specialty medications, generic drugs, vaccines, and medical supplies. This delivery order for ondansetron, an antiemetic medication commonly used in military and federal healthcare settings, represents routine pharmaceutical fulfillment under the company's comprehensive DLA contract vehicle designed to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FA0RE?
SPE2DR26FA0RE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FA0RE worth?
The government has obligated $10,905 on SPE2DR26FA0RE.
Is contract SPE2DR26FA0RE an order under another contract?
Yes. SPE2DR26FA0RE is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA0RE competed?
The extent of competition for SPE2DR26FA0RE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award